GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pheton Holdings Ltd (NAS:PTHL) » Definitions » Cyclically Adjusted PS Ratio

PTHL (Pheton Holdings) Cyclically Adjusted PS Ratio : (As of Apr. 26, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Pheton Holdings Cyclically Adjusted PS Ratio?

Pheton Holdings does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pheton Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Pheton Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pheton Holdings Cyclically Adjusted PS Ratio Chart

Pheton Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
- - - -

Pheton Holdings Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial - - - - -

Competitive Comparison of Pheton Holdings's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Pheton Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pheton Holdings's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pheton Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Pheton Holdings's Cyclically Adjusted PS Ratio falls into.


;
;

Pheton Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Pheton Holdings does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.


Pheton Holdings  (NAS:PTHL) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Pheton Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Pheton Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pheton Holdings Business Description

Traded in Other Exchanges
N/A
Address
Hong Jun Ying South Road, Room 306, NET Building, Chaoyang District, Beijing, CHN, 100101
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

Pheton Holdings Headlines